The Effect and Safety of Moxibustion Therapy for Overactive Bladder Patients

A Pilot Study About The Effects of Indirect-Moxibustion on Bladder- Functional Improvement and Symptoms Management in Patients With Overactive Bladder: A Randomized Controlled Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02271607

Enrollment

Registered

2014-10-22

Start date

2014-10-31

Completion date

2015-12-31

Last updated

2016-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperthermia, Lower Urinary Tract Symptoms, Overactive Bladder, Urinary Frequency or Urgency Adverse Event

Keywords

moxibustion

Brief summary

This pragmatic randomized controlled study aimed to evaluate the effectiveness and safety of moxibustion therapy on overactive bladder (OAB) patients.

Detailed description

Patients who diagnosed as overactive bladder aged 20 to 75 years old will be divided into two groups, one is moxibustion-therapy and the other is waiting-list group. Patients who belong to moxibustion therapy group will be treated moxibustion for 12 times by a Korean Medicine doctor. Patients who belong to waiting-list group will be prohibited to get any treatment including moxibustion for relieve the symptoms of overactive bladder, and the same moxibustion therapy with moxbiustion-therapy group will be conducted after 4 weeks. Overactive bladder symptom score (OABSS), overactive bladder-validated 8-question (OAB-V8) will be measured to evaluate the effectiveness. The number of side effect will be measured to evaluate the safety. The skin temperature of CV4, SP6 and LR3, and the tympanic temperature will be measured to study treatment mechanism.

Interventions

DEVICEmoxibustion

The treatment schedule is three times per week for four weeks. Indirect moxa pillars and indirect-container moxibustion will be used.

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 75 Years

Healthy volunteers

Inclusion criteria

1. aged from 20 to 75 years old 2. submit written consent 3. no deficit to notify the hotness promptly and exactly 4. diagnosed with overactive bladder 5. suffering the OAB symptoms during greater than or equal to 3 months

Exclusion criteria

1. malignancy 2. obstructive disease of urinary tract 3. cystocele, vaginocele or rectocele 4. urinary tract infection finding on urine analysis 5. diabetic mellitus 6. sensory disturbance 7. pregnancy, possibility of pregnancy or planning to pregnancy 8. problems to communication due to any medical problem such as cognitive dysfunction 9. getting other treatment of either Traditional Korean Medicine or conventional medicine for overactive bladder 10. psychiatric disorder or severe systemic disease.

Design outcomes

Primary

Measure	Time frame	Description
Overactive bladder-validated 8-questions	4 weeks	This is to measure how the patients have been bothered by OAB.

Secondary

Measure	Time frame	Description
Overactive bladder symptom scores	4, 8 weeks	self-administered questionnaire about daytime frequency, nighttime frequency, urgency and urgency incontinence.
The skin temperature of CV4, SP6 and LR3	4, 8 weeks	this is to establish the foundation of researching moxibustion-therapy mechanism.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026